# eureKARE

> eureKARE is a VC fund in Luxembourg backing Biotechnology and Medical. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Luxembourg, Luxembourg
- Total investments: 4
- Last investment: Nov 2022
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/eurekare/
- X (Twitter): https://twitter.com/eureKAREfr
- Website: https://eurekare.eu/
- Facebook: https://www.facebook.com/EureKareOfficial

eureKARE is a VC fund in Luxembourg focused on Biotechnology and Medical. eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.

## Contacts

5 contacts available for eureKARE. Shizune tracks 2 team members at eureKARE. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/eurekare?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 75% |
| Medical | 2 | 50% |
| Health Care | 2 | 50% |
| Life Science | 2 | 50% |
| Genetics | 1 | 25% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 25% |
| Series B | 1 | 25% |
| Series C | 1 | 25% |
| Corporate Round | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alexandre Mouradian | Founder & Chairman | 1 | https://shizune.co/investors/profile/alexandre-mouradian |
| Rodolphe Besserve | CEO | 1 | https://shizune.co/investors/profile/rodolphe-besserve |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Biomemory | Biomemory is a deep-tech company specializing in enterprise data storage. It uses molecular engineering to develop cost-effective, energy-efficient exabyte-scale appliances for data centers. | $5.2M | Seed | Nov 28, 2022 |  |
| DNA Script | DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results. | $35M | Series C | Jan 04, 2022 |  |
| Gynov | Gynov focuses on the development of innovative solutions dedicated to women's health issues. |  | Corporate Round | Nov 25, 2021 |  |
| Coave Therapeutics | Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases. | $38.9M | Series B | Jul 21, 2021 |  |

4 of 4 investments shown.

## Co-investors
- [Baillie Gifford](https://shizune.co/investors/profile/baillie-gifford) — VC Fund, 1 deal together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 1 deal together
- [Casdin Capital](https://shizune.co/investors/profile/casdin-capital) — VC Fund, 1 deal together
- [Catalio Capital Management](https://shizune.co/investors/profile/catalio-capital-management) — VC Fund, 1 deal together
- [Coatue](https://shizune.co/investors/profile/coatue) — VC Fund, 1 deal together
- [Columbia Threadneedle Investments](https://shizune.co/investors/profile/columbia-threadneedle-investments) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does eureKARE invest in?

eureKARE invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Series B stage. Most of the 4 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact eureKARE?

Public channels for eureKARE include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at eureKARE?

The team at eureKARE includes Alexandre Mouradian (Founder & Chairman) and Rodolphe Besserve (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co